Mirae Asset Global Etfs Holdings Ltd. Adma Biologics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 117,919 shares of ADMA stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,919Holding current value
$2.65 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
301Shares Held
180MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$419 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$326 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$284 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$201 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$181 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.41B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...